Generic Approvals Continue to Speed Forward

Generic Line
The FDA approved the most generic drugs during May and June since it began tallying approvals, according to the agency’s latest report on the generics program — helping Commissioner Scott Gottlieb make good on his early promises to speed generics to market in an effort to lower U.S. drug prices.

To View This Article:


Subscribe To Generic Line